David Oliver: Don’t blame GPs for late cancer diagnoses
BMJ 2019; 366 doi: https://doi.org/10.1136/bmj.l4625 (Published 17 July 2019) Cite this as: BMJ 2019;366:l4625All rapid responses
Rapid responses are electronic comments to the editor. They enable our users to debate issues raised in articles published on bmj.com. A rapid response is first posted online. If you need the URL (web address) of an individual response, simply click on the response headline and copy the URL from the browser window. A proportion of responses will, after editing, be published online and in the print journal as letters, which are indexed in PubMed. Rapid responses are not indexed in PubMed and they are not journal articles. The BMJ reserves the right to remove responses which are being wilfully misrepresented as published articles or when it is brought to our attention that a response spreads misinformation.
From March 2022, the word limit for rapid responses will be 600 words not including references and author details. We will no longer post responses that exceed this limit.
The word limit for letters selected from posted responses remains 300 words.
Good to see a headline don't blame the GP.
Yes we can do better.
But the data also needs to be questioned. If I as GP refer for a CT after waiting weeks for an appointment and it then shows something sinister the patient will often then be sent from diagnostic imaging to a/e and count as a missed GP diagnosis.
When we have conducted look back exercises in our own practice at confirmed cancer the pick up rate ie referral for suspected cancer is well above the quoted figures.
We also have confusing guidelines from learned journals. Recently The BMJ has as a reference that high platelet count indicated about a 13% risk of cancer but the leading article suggested a re-test in 3 months... GPs cannot access many test advised by NICE as the CCG won't pay or the trust won't do. All very frustrating before you even get to the point of trying to spot the person with possible cancer from those with nearly but not quite identical symptoms that keep us on our toes every day. If all were to be referred the creaky NHS would probably provide a worse service overall.
Competing interests: No competing interests
Editor
I thank Dr Crawford for his response and I think we are in broad agreement.
I have acknowledged in this and other columns that as he puts it "the NHS isn't big enough". The GP workforce numbers have been flat at best over the past decade or more at a time when the volumne and complexity of work and range of expectations have risen, community nursing and social care have been cut and the population demographic and pressure on acute hospital beds means ever more complex and unstable patients are on their caseload.
Meanwhile we have among the fewest doctors, nurses, beds and scanners per 1000 population among OECD nations and relentless pressure on hospital services. There are growing workforce gaps in secondary care too, with around 1 in 9 medical posts unfilled and currently around 40% of consultant physician posts unfilled at interview. The pressure on vital diagnostic services so relevant to cancer such as endoscopy and radiology is relentless and they would be overwhelmed if even more referrals came their way - especially those with urgent access time targets attached. There are similar pressures on specialities most likely to diagnose cancer and to refer for Oncology or surgical input. We have relatively few oncologists per 1000 population compared to many developed nations and elective surgery is struggling to meet waiting times.
In this environment and with many of those disciplines having to balance cancer work with many other clinical conditions and priorities, we absolutely cannot attribute all disparities in cancer outcomes compared to other nations to our GP gatekeeper/first consultation model.
I pointed out clearly that most patients diagnosed with cancer had in fact seen their GP and that diagnosis on emergency presentation to hospital was not the norm.
I was also careful to make the point that it wasn't the Cancer Research UK report's intention to blame GPs, but that unfortunately this was how such reports were sometimes reported in mainstream media, especially in headlines more sensationalist than details in the body of the article.
I have acknowledged in numerous pieces that our outcomes for some conditions in the NHS are mediocre by OECD or EU standards.
On reflection, I think the only major difference of emphasis I can see between Dr Crawford and me is that he seems (and forgive me if I have misunderstood) to be arguing that even the threshold of 3% positive predictive value recommended by NICE for cancer referral by GPs is perhaps too restrictive; that GPs seeing people with early, undifferentiated symptoms which might well not be cancer at all - let alone red flags for cancer - should refer urgently regardless and that we should copy some other nations where patients can bypass the GP referral process and self refer direct to a specialist of their choice.
Given that our system is already struggling for resources, staffing, availability of investigations and funding, such an approach would at the very least need strong initial evaluation looking at cost, opportunity costs for non cancer patients or other service lines, sustainability and impact before becoming the new norm. Then again, if it's good for stroke, why not make it the norm for other potentially life limiting medical conditions like heart, kidney or lung disease?
I am a geriatrician and general internal medicine physician working in acute care, Dr Crawford is an Oncologist. It would be really interesting to get a take on his suggestions from some GPs who do the referring and gatekeeping.
I am fed up with seeing GPs being bashed repeatedly in headlines and will continue to defend them vigorously
David Oliver
Competing interests: No competing interests
Oliver[1] draws attention to press reports of the CRUK report on diagnostic timeliness for cancer[2]. The fact is that the constituent countries of the UK are at the bottom of the pile among the developed economies of Europe for cancer survival[3] and they all, along with the Republic of Ireland and Denmark which also do poorly, have primary care consultations as the starting point for the preferred pathway to cancer diagnosis. Denmark seems to be doing better these days.
The poor survival record of UK countries is confirmed by cancer benchmarking studies. One such showed that GPs differ in different jurisdictions in the way they handle cancer referrals with UK GPs being less likely to investigate in a given scenario [4]. This consistent reluctance to refer patients along the pathway of management of potential and indeed confirmed cancer has been evident for many years[5].
It is therefore right not to see the CRUK report as blaming general practitioners for the delays that were described. It is a cultural phenomenon and this is not a good culture. I do not agree with Oliver that denying people access to urgent referral pathways is an acceptable way of moderating demand especially those whose presentation fits NICE referral guidelines. Rather it emphasises the need for NHS England to ensure that the personnel and technology are available in accessible premises to ensure adequate diagnostic and therapeutic capacity for all cases.
Oliver is concerned that patients risk being referred down the wrong specialist route yet in the countries that have better survival statistics it is the patient who has to guess who is the most appropriate specialist to consult; that doctor must then make an onward referral if the guess is wrong. He quotes evidence that some patients diagnosed through emergency presentation have not consulted a GP[6]; they can be inhibited from doing so because appointments are “like gold dust” to quote one of mine. Matthew Parris has described the inhibiting effect of difficult GP access on discussing a potential cancer[7]. The majority of patients in the study he quotes had seen a GP which fits with the findings of the benchmarking study [4].
Furthermore, in quoting performance against operational standards it is necessary to remember that to record within 62 days of referral a decision that a patient with lung cancer is too unfit to receive active treatment meets that standard. If that patient’s GP 6 months previoulsy made a decision that a normal chest X-ray 6 months before that meant that a further radiograph to investigate a persistent cough was an unnecessary burden on the imaging department, that goes unremarked.
The fact that even this performance target is becoming hard to meet emphasises that the NHS is too small to meet the needs of cancer patients. To respond to this simply by revising the target is to misunderstand its message. We know all this about cancer services because of the amount of big data that is available. These observations are likely to be applicable more widely.
References
1] Oliver D. Don’t blame GPs for late cancer diagnoses. BMJ 2019;366:l4625
2] Pearson C, Fraser J, Peake M, et al. Establishing population-based surveillance of diagnostic timeliness using linked cancer registry and administrative data for patients with colorectal and lung cancer. Cancer Epidemiol2019;61:111-8.
3] Baili P, Di Salvo F, Marcos-Gragera R et al.; EUROCARE-5 Working Group. Age and case mix-standardised survival for all cancer patients in Europe 1999–2007: results of EUROCARE-5, a population-based study. Eur J Cancer 2015; 51: 2120–9.
4] Rose PW, Rubin G, Perera-Salazar R et al. Explaining variation in cacner survival between 11 jurisdictions in the International Cancer Benchmarking Partnership: a primary care vignette survey. BMJ Open 2015; 5: e007212.
5] Crawford SM. Cancer in the UK- A question of culture. Eur J Cancer, 2000; 36: 1909-12.
6] Abel GA, Mendonca SC, McPhail S, Zhou Y, Elliss-Brookes L, Lyratzopoulos G. Emergency diagnosis of cancer and previous general practice consultations: insights from linked patient survey data. Br J Gen Pract2017;67:e377-87. doi:10.3399/bjgp17X690869.
7] Parris M. The Times 7th July 2018
Competing interests: No competing interests
The public often mocks our medical care for “wrong” and “late” diagnoses.<1> But isn't using "time as a test" a tool physicians have been taught to aid our differential diagnoses? <2>
The onset of illness and disease progression could be tell-tale signs of a medical condition. When I am at hospital taking referrals, I am often thankful to the preliminary workups performed in primary care, as they help me to rule out some differentials.
Differential diagnosis means determining the most likely cause of an illness based on a list of most possible explanations. There are always chances that the most likely explanation can be wrong. If clinicians have worked long enough, they must have made a wrong differential diagnosis at least once in their career. But does it mean they are unsafe? Usually, when patient fails to improve on initial management, clinicians would consider other likely causes of the illness.
There are often derogatory implications when the media reports patient having the "wrong" or "late" diagnoses. But let us look at another scenario. A patient presents with systemic inflammatory response syndrome in an emergency department. The emergency doctors start antibiotics for query pneumosepsis and refer to internal medicine. When the medicine team perform a more thorough assessment, they suspect pulmonary embolism and order a chest computed tomography, which later confirms their suspicion. Patient eventually receives the standard treatment and is safely discharged home days later, praising the care received. But in such a scenario, should we penalise the emergency doctor for making the wrong diagnosis of pneumosepsis in a time-critical situation? Or should we mock the patient's general practitioner for missing the pulmonary embolism in the community?
These news media articles about "late" and "wrong" diagnoses serve the purpose of damaging doctor-patient trust, and do little to improve our healthcare system.
References
1. Oliver D. David Oliver: Don't blame GPs for late cancer diagnoses. BMJ. 2019;366:l4625.
2. Spence D. Bad medicine: reassurance? Br J Gen Pract. 2018;68(670):239-239.
Competing interests: I have been paid for working as a physician but not writing this letter.
The headlines about late diagnosis of cancers feeds into a false narrative where the public are misled to believe that if a disease -any chronic disease for that matter- has been diagnosed a bit earlier, the outcome would have been vastly superior.[1].
Firstly, it is virtually impossible to exhaustively investigate every possible symptom for all sorts of disease all the time without bankrupting the National Health Service. The General practitioners are forced to assess pre-test probabilities and the symptoms with a high likelihood of a particular disease are investigated immediately and the symptoms with a low likelihood of a particular disease are kept under observation.[2].
Secondly, even if a disease can be diagnosed earlier by a few weeks, there is no guarantee that the outcome would have been any different. For many cancers, the biology of the disease is far more important in determining the outcome and a few weeks delay would not make any significant difference to the outcome of vast majority of patients. Genetic studies now confirm the clinical intuition that some cancers are just born bad and early diagnosis is unlikely to cure them [3].
References
1 Oliver D. David Oliver: Don’t blame GPs for late cancer diagnoses. BMJ 2019;366:l4625. doi:10.1136/bmj.l4625
2 Gill CJ, Sabin L, Schmid CH. Why clinicians are natural bayesians. BMJ 2005;330:1080–3. doi:10.1136/bmj.330.7499.1080
3 Turajlic S, Xu H, Litchfield K, et al. Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal. Cell 2018;173:581–594.e12. doi:10.1016/j.cell.2018.03.057
Competing interests: No competing interests
Continued discussion with David Oliver: Don’t blame GPs for late cancer diagnoses
I can assure Professor Oliver that I am very comfortable with the 3% probability for cancer being present as the threshold on which the cancer referral guidelines are based. I also support research into more vague symptoms which might indicate malignancy as a basis for further investigation; this is not yet ready for routine practice.
The concern I have is that in both his article and his response he seems to be arguing that the lack of resources in the NHS, which I summarised as its smallness and which the Royal College of Physicians of London summarised as the Service being “underdoctored, underfunded and overstretched” in its report a few years ago, is a reason to deny patients whose presentation fits the referral criteria the opportunity. To do so in an unstructured way will perpetuate the social and geographical inequalities of access which are evident in studies of NHS cancer outcomes[1]. The referral guidelines are the rationing criteria which seek to attain optimal outcomes without Continental style direct access.
This does mean that there will be increased stresses in the service. We do need to act as advocates for our patients and when trusts and CCGs deny access as Dr Sharvill describes, this should be called out.
Whatever the economic justification for austerity its effect on health services needs to be clearly understood. Whilst the money from the Treasury has risen very slightly faster than inflation the drive for improvement in--for example, cancer services and mental health services and the issue of the ageing babyboom generation--means that the amount of resource in relation to need has been cut. The demographic component has been predictable for seven decades but seems not to have been accounted for.
It is also important to recognise that whilst presentation via the emergency department usually reflects an inappropriate way to access specialist care, and I note Dr Sharvill’s observations, referral by the GP does not always mean that the patient’s journey has been optimal. All is well when the patient with a colonic tumour is referred promptly with altered bowel habit but if after such a presentation the disease is allowed to progress a referral from primary care with hepatomegaly is not a triumph. The 1- and 5-year survival data are the most objective way to measure a healthcare system’s performance.
1] Murage P, Crawford SM, Bachmann M, Jones A. Geographical disparities in access to cancer management and treatment services in England. Health & Place, Health and Place 2016; 42:11-18.
Competing interests: No competing interests